DocGo Inc. (DCGO) · Insider trading
What DocGo's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$15,334
1 insider, 0% under a plan
Net, 12 months
−$15,334
bought less sold
Latest filing
2026-05-14
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Tendler Ely DDirector, General Counsel and Secretary | – | $117,844 | 2 | 2025-12-15 | 258,795 |
| Leite EtalvinaDirector | – | $71,610 | 1 | 2024-12-17 | 51,411 |
| Burdiek Michael JDirector | $34,750 | – | 2 | 2025-05-23 | 641,560 |
| Bienstock LeeDirector, Chief Executive Officer | $23,100 | – | 1 | 2025-05-14 | 1,971,079 |
| Klasko Stephen K. M.d.Director | $22,350 | – | 1 | 2025-05-14 | 15,000 |
| Rosenberg NormanCFO and Treasurer | $22,050 | – | 1 | 2025-05-14 | 871,272 |
| Sugrue StephenChief Compliance Officer | $14,400 | – | 1 | 2025-05-14 | 357,328 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Tendler Ely DDirector, General Counsel and Secretary | Sale | 16,850 | 0.91 | $15,334 | 258,795 | Form 4 |
| 2025-05-23 | Burdiek Michael JDirector | Buy | 10,000 | 1.33 | $13,300 | 641,560 | Form 4 |
| 2025-05-15 | Burdiek Michael JDirector | Buy | 15,000 | 1.43 | $21,450 | 631,560 | Form 4 |
| 2025-05-14 | Bienstock LeeDirector, Chief Executive Officer | Buy | 15,000 | 1.54 | $23,100 | 1,971,079 | Form 4 |
| 2025-05-14 | Rosenberg NormanCFO and Treasurer | Buy | 15,000 | 1.47 | $22,050 | 871,272 | Form 4 |
| 2025-05-14 | Sugrue StephenChief Compliance Officer | Buy | 10,000 | 1.44 | $14,400 | 357,328 | Form 4 |
| 2025-05-14 | Klasko Stephen K. M.d.Director | Buy | 15,000 | 1.49 | $22,350 | 15,000 | Form 4 |
| 2024-12-17 | Leite EtalvinaDirector | Sale | 16,500 | 4.34 | $71,610 | 51,411 | Form 4 |
| 2024-12-16 | Tendler Ely DDirector, General Counsel and Secretary | Sale | 23,088 | 4.44 | $102,511 | 175,645 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
22 × shares withheld for tax20 × grant or award
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-12 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −15,644 | 0.59 | 2,801,826 | Form 4 |
| 2026-03-30 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −18,811 | 0.57 | 2,817,470 | Form 4 |
| 2025-12-15 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −65,774 | 0.91 | 1,223,571 | Form 4 |
| 2025-12-15 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −35,968 | 0.91 | 636,602 | Form 4 |
| 2025-12-15 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −214,131 | 0.91 | 2,836,281 | Form 4 |
| 2025-12-12 | Travers James MDirector | Grant or award A | +150,000 | – | 240,999 | Form 4 |
| 2025-12-12 | Burdiek Michael JDirector | Grant or award A | +150,000 | – | 791,560 | Form 4 |
| 2025-12-12 | Tendler Ely DDirector, General Counsel and Secretary | Grant or award A | +100,000 | – | 275,645 | Form 4 |
| 2025-12-12 | Rosenberg NormanCFO and Treasurer | Grant or award A | +429,405 | – | 1,289,345 | Form 4 |
| 2025-12-12 | Leite EtalvinaDirector | Grant or award A | +150,000 | – | 201,411 | Form 4 |
| 2025-12-12 | Smedra IraDirector | Grant or award A | +150,000 | – | 240,999 | Form 4 |
| 2025-12-12 | Sugrue StephenChief Compliance Officer | Grant or award A | +321,055 | – | 672,570 | Form 4 |
| 2025-12-12 | Bienstock LeeDirector, Chief Executive Officer | Grant or award A | +1,113,495 | – | 3,050,412 | Form 4 |
| 2025-09-10 | Klasko Stephen K. M.d.Director | Grant or award A | +100,000 | – | 115,000 | Form 4 |
| 2025-07-02 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −18,597 | 1.52 | 1,936,917 | Form 4 |
| 2025-07-02 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −11,332 | 1.52 | 859,940 | Form 4 |
| 2025-07-02 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −5,813 | 1.52 | 351,515 | Form 4 |
| 2025-05-13 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −15,565 | 1.44 | 1,955,514 | Form 4 |
| 2025-04-02 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −18,598 | 2.68 | 1,956,079 | Form 4 |
| 2025-04-02 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −8,004 | 2.68 | 856,272 | Form 4 |
| 2025-04-02 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −5,614 | 2.68 | 347,328 | Form 4 |
| 2025-03-31 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −18,742 | 2.64 | 1,974,677 | Form 4 |
| 2025-03-07 | Bienstock LeeDirector, Chief Executive Officer | Grant or award A | +465,116 | – | 2,052,779 | Form 4 |
| 2025-03-07 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −59,360 | 3.03 | 1,993,419 | Form 4 |
| 2025-03-07 | Rosenberg NormanCFO and Treasurer | Grant or award A | +170,543 | – | 879,646 | Form 4 |
| 2025-03-07 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −15,370 | 3.03 | 864,276 | Form 4 |
| 2025-03-07 | Sugrue StephenChief Compliance Officer | Grant or award A | +77,520 | – | 360,731 | Form 4 |
| 2025-03-07 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −7,789 | 3.03 | 352,942 | Form 4 |
| 2025-01-02 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −18,598 | 4.23 | 1,587,663 | Form 4 |
| 2025-01-02 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −9,180 | 4.23 | 709,103 | Form 4 |
| 2025-01-02 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −4,708 | 4.23 | 283,211 | Form 4 |
| 2024-12-13 | Leite EtalvinaDirector | Grant or award A | +34,965 | – | 67,911 | Form 4 |
| 2024-12-13 | Bienstock LeeDirector, Chief Executive Officer | Shares withheld for tax F | −86,236 | 4.19 | 1,606,261 | Form 4 |
| 2024-12-13 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax F | −19,213 | 4.19 | 718,283 | Form 4 |
| 2024-12-13 | Sugrue StephenChief Compliance Officer | Shares withheld for tax F | −8,734 | 4.19 | 287,919 | Form 4 |
| 2024-12-13 | Burdiek Michael JDirector | Grant or award A | +34,965 | – | 616,560 | Form 4 |
| 2024-12-13 | Smedra IraDirector | Grant or award A | +34,965 | – | 90,999 | Form 4 |
| 2024-12-13 | Travers James MDirector | Grant or award A | +34,965 | – | 90,999 | Form 4 |
| 2024-12-12 | Bienstock LeeDirector, Chief Executive Officer | Grant or award A | +536,993 | – | 1,692,497 | Form 4 |
| 2024-12-12 | Rosenberg NormanCFO and Treasurer | Grant or award A | +346,062 | – | 737,496 | Form 4 |
| 2024-12-12 | Sugrue StephenChief Compliance Officer | Grant or award A | +107,399 | – | 296,653 | Form 4 |
| 2024-12-12 | Tendler Ely DDirector, General Counsel and Secretary | Grant or award A | +35,800 | – | 198,733 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.